Cytheris Report issue

For profit Phase 2
Founded: Issy-les-moulineaux France (1999)
Status: Defunct (2013)

Organization Overview

First Clinical Trial
2007
NCT00477321
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2011

Timeline

NOW
  • Now

Alternative names

Cytheris, Inc. | Cytheris SA

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Breast Neoplasms (Phase 2)

Carcinoma, Renal Cell (Phase 1)

Hepatitis (Phase 2)

Hepatitis A (Phase 2)

Hepatitis B (Phase 2)

Hepatitis B, Chronic (Phase 2)

Hepatitis C (Phase 2)

Hepatitis, Chronic (Phase 2)

HIV Infections (Phase 1)

Kidney Neoplasms (Phase 1)

Lymphopenia (Phase 2)

Melanoma (Phase 1)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 11
  • # of Trial APIs: 7